Acute Respiratory Infections
Scandrett K, Colquitt J, Court R et al Rapid tests to inform triage and antibiotic prescribing decisions for adults presenting with suspected acute respiratory infection: a rapid evidence synthesis of clinical effectiveness and cost-utility studies. Health Technology Assessment 2025: 29 (13).
Asthma
Main C, Shepherd J, Anderson R, Rogers G, Thompson-Coon J, Lui Z, Hartwell D, Loveman E, et al. Inhaled corticosteroids and Long Acting Beta-2 Agonists for the treatment of chronic asthma in children under the age of 12 years: Systematic review and economic analysis. Health Technology Assessment 2008;12(20).
Shepherd J, Rogers G, Anderson R, Main C, Thompson-Coon J, Hartwell D, Lui Z, Loveman E, et al. Inhaled corticosteroids and Long Acting Beta-2 Agonists for the treatment of chronic asthma in adults and children aged 12 years and over: systematic review and economic analysis. Health Technology Assessment 2008;12(9).
Idiopathic pulmonary fibrosis
Bajwah S, Colquitt J, Loveman E, et al. Pharmacological and non-pharmacological interventions to improve symptom control, functional exercise capacity and quality of life in interstitial lung disease: an evidence synthesis. ERJ Open Res Jan 2021, 7 (1) 00107-2020
Scott, DA, Loveman E, Colquitt JL, O’Reilly K. Choice of Methodology Impacts Outcome in Indirect Comparisons of Drugs for Idiopathic Pulmonary Fibrosis. Medicina 2019, 55(8), 443; doi:10.3390/medicina55080443
Loveman E, Copley V, Scott DA, Colquitt JL, Clegg AJ, O’Reilly K. Comparing new treatments for idiopathic pulmonary fibrosis: a network meta-analysis. BMC Pulmonary Medicine 2015: 15 (37)
Loveman E, Copley V, Colquitt JL, Scott D, Clegg A, Jones J, O’Reilly K, Singh S, Bausewein C, Wells A. The clinical and cost effectiveness of treatments for idiopathic pulmonary fibrosis: a systematic review and economic evaluation. Health Technology Assessment 2015; 19(20)
Loveman E, Copley VR, Colquitt JL, Scott DA, Clegg AJ, Jones J, O’Reilly KMA, et al. The effectiveness and cost-effectiveness of treatments for Idiopathic Pulmonary Fibrosis: systematic review, network meta-analysis and health economic evaluation. BMC Pharmacology and Toxicology 2014; 15 (63).